Syncom Formulations sets record date for ₹0.10 final dividend
- Syncom Formulations fixes September 23, 2026, as the record date for its final dividend
- The proposed payout is ₹0.10 per equity share of face value ₹1 for FY26
- Shareholder approval at the AGM on September 30, 2026, is required for the payout
- Dividend waivers must be submitted by September 26, 2026

*this image is generated using AI for illustrative purposes only.
Syncom Formulations has fixed September 23, 2026, as the record date for determining shareholder eligibility for its final dividend for FY26. The company proposes a payout of ₹0.10 per equity share of face value ₹1 each.
The dividend declaration is subject to approval by members at the company’s 38th Annual General Meeting (AGM). The AGM is scheduled to be held on September 30, 2026, at 2:00 pm via video conferencing or other audio-visual means.
Dividend Details
The final dividend relates to the financial year ended March 31, 2026. Shareholders on record as of September 23, 2026, will be eligible to receive the payout if approved by shareholders.
| Metric | Detail |
|---|---|
| Dividend Rate | 10% |
| Amount Per Share | ₹0.10 |
| Face Value | ₹1 |
| Record Date | September 23, 2026 |
| Financial Year | FY26 |
Waiver Process
Shareholders who wish to voluntarily waive their entitlement to the dividend, either in full or in part, must submit a duly filled and signed Dividend Waiver Form. The form is available on the company’s website.
Completed forms must be sent to the company or its Registrar and Transfer Agent (RTA) on or before September 26, 2026. This deadline ensures the waiver is processed before the dividend payment date.
Regulatory Disclosure
The announcement was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act, 2013.
Historical Stock Returns for Syncom Formulations
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.39% | +3.74% | +31.27% | +72.84% | +11.00% | +146.67% |
How does the proposed ₹0.10 dividend per share compare to Syncom Formulations' payout history and peer averages in the pharmaceutical sector?
What is the expected impact of this dividend payout on the company's retained earnings and future capital allocation strategies for FY27?
Will the 38th AGM address any strategic initiatives or operational updates alongside the dividend approval?


































